The global bronchoscopes market is witnessing strong growth as healthcare providers increasingly focus on early and accurate diagnosis of respiratory diseases. Rising cases of lung cancer, chronic obstructive pulmonary disease, asthma, and infectious respiratory conditions are increasing the need for advanced pulmonary diagnostic procedures. Bronchoscopes are widely used to examine the airways and support procedures such as tissue biopsy, bronchoalveolar lavage, secretion management, tumor intervention, and airway stenting. At the same time, technological advances are transforming bronchoscopy through robotic-assisted navigation, high-definition imaging, endobronchial ultrasound, artificial intelligence, and single-use systems. These innovations are improving lesion targeting, diagnostic accuracy, procedural efficiency, and infection control, making bronchoscopes increasingly important in modern respiratory care.

Key Market Statistics

The global bronchoscopes market was valued at USD 1.0 billion in 2025 and is estimated to reach USD 1.1 billion in 2026. The market is projected to reach USD 2.3 billion by 2033, expanding at a CAGR of 10.9% from 2026 to 2033. North America accounted for the largest regional revenue share of 38.8% in 2025, while Asia Pacific is expected to register the fastest CAGR during the forecast period. The U.S. dominated the North American bronchoscopes market in 2025.

By product, reusable bronchoscopes accounted for 76.5% of market revenue in 2025. Hospitals represented the largest end-use segment, with a 57.3% revenue share in 2025. The market is also experiencing increasing adoption of single-use bronchoscopes, particularly in critical care environments where reducing cross-contamination and reprocessing requirements is a priority.

Download a free sample copy of the Bronchoscopes market report to understand detailed coverage and inclusions in the final report

Market Drivers & Risks

The increasing incidence of respiratory diseases is a major driver of the bronchoscopes market. Rising lung cancer prevalence and the growing burden of COPD, asthma, and respiratory infections are increasing demand for diagnostic and therapeutic bronchoscopy. Early detection is particularly important for lung cancer because timely diagnosis can support treatment decisions and improve patient outcomes. Growing awareness about minimally invasive procedures is also encouraging healthcare providers to adopt advanced bronchoscopy systems.

Technological innovation is another important growth factor. Robotic-assisted bronchoscopy and navigation systems allow physicians to access peripheral lung nodules that can be difficult to reach using conventional methods. Navigation technologies, virtual bronchoscopy, CT-guided mapping, and advanced imaging can improve lesion targeting and procedural accuracy. Endobronchial ultrasound is also expanding the diagnostic capabilities of bronchoscopes by supporting lung cancer staging and tissue sampling.

However, infection risk and procedure-related complications remain important market restraints. Reusable bronchoscopes require strict cleaning, sterilization, and reprocessing procedures, and inadequate sterilization can increase cross-contamination risks. Bronchoscopy can also involve complications such as bleeding, pneumothorax, and respiratory distress. These concerns can influence procedure volumes and encourage healthcare providers to consider single-use alternatives.

Market Breakdown and Core Segments

• By product, the reusable bronchoscopes segment dominated the market with a 76.5% revenue share in 2025. Reusable systems are widely used across pulmonology, thoracic surgery, critical care, oncology, and interventional bronchoscopy. They support a broad range of procedures, including airway examination, bronchoalveolar lavage, tissue biopsy, secretion management, foreign body removal, and tumor intervention.
• The single-use bronchoscopes segment is expected to grow at the fastest CAGR during the forecast period. Increasing awareness of hospital-acquired infections and cross-contamination risks is encouraging hospitals to consider disposable systems. Single-use devices can reduce the need for reprocessing and provide sterile equipment for individual procedures, particularly in intensive care and emergency settings.
• By end use, hospitals held the largest share of 57.3% in 2025. Hospitals remain major centers for complex pulmonary diagnosis, respiratory care, thoracic surgery, oncology, and emergency procedures. The outpatient facilities segment is expected to record the fastest CAGR from 2026 to 2033 as healthcare systems increasingly shift non-emergency pulmonary diagnostics toward same-day and outpatient settings.

Looking for more specific insights? Customize this report to suite your business needs

Leading Industry Players

Major companies operating in the bronchoscopes market include Olympus Corporation, Ambu A/S, Teleflex Incorporated, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, PENTAX Medical, Cook, Broncus Medical, Johnson & Johnson, and Praxis Medical. These companies are focusing on advanced imaging, robotic-assisted systems, single-use bronchoscopes, navigation technologies, and integrated pulmonary intervention platforms.

Companies are also using product launches and strategic partnerships to strengthen their market positions. In January 2026, FUJIFILM Healthcare Europe launched the EB-710US balloonless ultrasonic bronchoscope for lung cancer detection and staging. In September 2025, Olympus launched its BF-UCP190F endobronchial ultrasound bronchoscope across the EMEA region. KARL STORZ received FDA clearance for its FIVE S 6.5 single-use bronchoscope in March 2026, while Olympus received FDA clearance in February 2026 for pediatric use of two H-SteriScope single-use video flexible bronchoscopes.

U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.